Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for TXTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 611.30M
March 31, 2026 611.31M
December 31, 2025 546.31M
September 30, 2025 511.31M
June 30, 2025 505.01M
March 31, 2025 255.01M
December 31, 2024 255.01M
September 30, 2024 55.01M
June 30, 2024 55.00M
March 31, 2024 15.00M
December 31, 2023 15.00M
September 30, 2023 15.17M
June 30, 2023 15.17M
March 31, 2023 15.17M
December 31, 2022 15.00M
September 30, 2022 0.2017M
June 30, 2022 0.2034M
March 31, 2022 0.2034M
December 31, 2021 0.17M
September 30, 2021 0.2034M
June 30, 2021 0.2034M
March 31, 2021 0.2034M
December 31, 2020
September 30, 2020
June 30, 2020
Date Value
March 31, 2020
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018 2.603M
September 30, 2018 2.603M
June 30, 2018 2.604M
March 31, 2018 2.604M
December 31, 2017 2.604M
September 30, 2017 2.604M
June 30, 2017 2.624M
March 31, 2017 2.608M
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014 0.0205M
June 30, 2014 0.0256M
March 31, 2014 0.0827M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Anika Therapeutics, Inc. 183.47M
Perspective Therapeutics, Inc. 392.02M
Achieve Life Sciences, Inc. 190.44M
MiMedx Group, Inc. 281.00M
ABVC BioPharma, Inc. 19.40M

Total Assets (Quarterly) Related Metrics